Cargando…

A neural basis for melanocortin-4 receptor regulated appetite

Pro-opiomelanocortin (POMC)- and agouti-related peptide (AgRP)-expressing neurons are oppositely regulated by caloric depletion and co-ordinately stimulate and inhibit homeostatic satiety, respectively. This bimodality is principally underscored by the antagonistic actions of these ligands at downst...

Descripción completa

Detalles Bibliográficos
Autores principales: Garfield, Alastair S., Li, Chia, Madara, Joseph C., Shah, Bhavik P., Webber, Emily, Steger, Jennifer S., Campbell, John N., Gavrilova, Oksana, Lee, Charlotte E., Olson, David P., Elmquist, Joel K., Tannous, Bakhos A., Krashes, Michael J., Lowell, Bradford B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446192/
https://www.ncbi.nlm.nih.gov/pubmed/25915476
http://dx.doi.org/10.1038/nn.4011
Descripción
Sumario:Pro-opiomelanocortin (POMC)- and agouti-related peptide (AgRP)-expressing neurons are oppositely regulated by caloric depletion and co-ordinately stimulate and inhibit homeostatic satiety, respectively. This bimodality is principally underscored by the antagonistic actions of these ligands at downstream melanocortin-4 receptors (MC4R) within the paraventricular nucleus of the hypothalamus. Although this population is critical to energy balance the underlying neural circuitry remains unknown. Enabled by mice expressing Cre-recombinase in MC4R neurons, we demonstrate bidirectional control of feeding following real-time activation and inhibition of PVH(MC4R) neurons and further identify these cells as a functional exponent of ARC(AgRP) neuron-driven hunger. Moreover, we reveal this function to be mediated by a PVH(MC4R)→lateral parabrachial nucleus (LPBN) pathway. Activation of this circuit encodes positive valence, but only in calorically depleted mice. Thus, the satiating and appetitive nature of PVH(MC4R)→LPBN neurons supports the principles of drive reduction and highlights this circuit as a promising target for anti-obesity drug development.